Inventor · disambiguated record
Janel Lape
Also filed as: LAPE JANEL
8 granted patents·9 pending applications·7 citations·filing 2018–2025
79Inventor score
Files withPREC BIOSCIENCES INC17
Top patents by PatentIndex Score
17 records- 0191US11142750B2Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genomePREC BIOSCIENCES INC·Filed 2019·Granted Oct 12, 2021·3 cites·6 claims
- 0290US11680254B2Engineered meganucleases specific for recognition sequences in the PCSK9 genePREC BIOSCIENCES INC·Filed 2018·Granted Jun 20, 2023·3 cites·8 claims
- 0384US2024035011A1Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genomePREC BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0481US12006522B2Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin genePREC BIOSCIENCES INC·Filed 2023·Granted Jun 11, 2024·0 cites·16 claims
- 0581US11993793B2Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin genePREC BIOSCIENCES INC·Filed 2023·Granted May 28, 2024·0 cites·16 claims
- 0679US11786554B2Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2019·Granted Oct 17, 2023·1 cites·5 claims
- 0779US2025034536A1Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin genePREC BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0878US11788077B2Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genomePREC BIOSCIENCES INC·Filed 2021·Granted Oct 17, 2023·0 cites·12 claims
- 0977US11753630B2Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin genePREC BIOSCIENCES INC·Filed 2022·Granted Sep 12, 2023·0 cites·11 claims
- 1076US2024000845A1Optimized engineered nucleases having specificity for the human t cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1172US2025171757A1Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genomePREC BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1271US2025346877A1Engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genomePREC BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1362US2025333468A1Optimized engineered nucleases having specificity for the human t cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1461US2025228973A1Gene editing methods for treating alpha-1 antitrypsin (aat) deficiencyPREC BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1559US2024299585A1Engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 genePREC BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1657US12410418B2Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genomePREC BIOSCIENCES INC·Filed 2020·Granted Sep 9, 2025·0 cites·12 claims
- 1756US2024011003A1Engineered meganucleases having specificity for a recognition sequence in the transthyretin genePREC BIOSCIENCES INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Janel Lape files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →